Evidence 1
Activity
Activity
8.4% Hemolysis
Toxicity
100-400 µg/mL
Hemolytic
Cytotoxic
8.4% Hemolysis | 100-400 | µg/mL | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
The effect of structural modification of antimicrobial peptides on their antimicrobial activity, hemolytic activity, and plasma stability. | J Pept Sci | 2021